Valproic Acid

survival of motor neuron 2, centromeric ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28389270 Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. 2017 Sep 2
2 25042492 [Effect of valproic acid on SMN protein level in peripheral blood mononuclear cells of patients with spinal muscular atrophy and different SMN2 copy numbers]. 2014 1
3 25143843 Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion. 2014 1
4 23077215 VPA response in SMA is suppressed by the fatty acid translocase CD36. 2013 Jan 15 4
5 21561730 Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. 2012 Mar 6
6 21610752 Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability. 2011 Oct 1
7 18025935 Clinical trials in spinal muscular atrophy. 2007 Dec 1
8 16508748 Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. 2006 May 1
9 16775228 Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. 2006 Aug 8 1
10 17027862 Spinal muscular atrophy: from gene to therapy. 2006 Jun 2
11 17076267 Spinal muscular atrophy and therapeutic prospects. 2006 2
12 12915451 Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. 2003 Oct 1 5